Pharmaceutical compositions and uses of inorganic pyrophosphates

Details Pharmaceutical compositions and uses of inorganic pyrophosphates Pharmaceutical compositions and uses of inorganic pyrophosphates

1997-08-29

1999-09-28

Jordan, Kimberly

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Phosphorus containing other than solely as part of an...

514114, 514851, 424601, A61K 3166, A61K 3342

Patent

active

059589078

ABSTRACT:
Pharmaceutical compositions comprising an inorganic pyrophosphate (PPi) in a form that renders the PPi accessible to ABC proteins when administered to a subject in vivo, as well as use of the compositions for treating subjects having a disease or disorder associated with inappropriate or inadequate ABC protein activity (e.g., cystic fibrosis, multi drug resistance, Zellweger's Syndrome) is disclosed.

REFERENCES:
patent: 5407661 (1995-04-01), Simone et al.
patent: 5686114 (1997-11-01), Welsh
Anderson, M.P. and M.J. Welsh (1992) "Regulation by ATP and ADP of CFTR Chloride Channels That Contain Mutant Nucleotide-Binding Domains" Science 257:1701-1704.
Anderson, M.P. et al. (1991) "Nucleoside Triphosphates Are Required to Open the CFTR Chloride Channel" Cell 67:775-784.
Bartels, E.M. et al. (1993) "The myosin molecule--charge response to nucleotide binding" Biochem. Biophys. Acta 1157:63-73.
Baukrowitz, T. et al. (1994) "Coupling of CFTR CI.sup.- Channel Gating to an ATP Hydrolysis Cycle" Neuron 12:473-482.
Berger, H.A. et al. (1993) "Regulation of the Cystic Fibrosis Transmembrane Conductance Regulator CI.sup.- Channel by Specific Protein Kinases and Protein Phosphatases" J. Biol. Chem. 268:2037-2047.
Bhalla, K. et al. (1985) "Isolation and Characterization of an Anthracycline-resistant Human Leukemic Cell Line" Cancer Res. 45:3657-3662.
Blobel, C.P. et al. (1992) "A potential fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion" Nature 356:248-251.
Busche, R. et al. (1989) "Equilibrium, kinetic and photoaffinity labeling studies of daunomycin binding to P-glycoprotein-containing membranes of multidrug-resistant Chinese hamster ovary cells" Eur. J. Biochem. 183:189-197.
Busche, R. et al. (1989) "Preparation and Utility of a Radioiodinated Analogue of Daunomycin in the Study of Multidrug Resistance" Mol. Pharmacol. 35:414-421.
Carson, M.R. et al. (1994) "Phosphate Stimulates CFTR CI.sup.- Channels" Biophys. J. 67(5):1867-1875.
Chen, C.-J. et al. (1986) "Internal Duplication and Homology with Bacterial Transport Proteins in mdr1 (P-Glycoprotein) Gene from Multidrug-Resistant Human Cells" Cell 47:381-389.
Croop, J.M. et al. (1988) "Genetics of Multidrug Resistance" J. Clin. Invest. 81:1303-1309.
Cutting, G.R. et al. (1990) "A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regular protein" Nature 346:366-369.
Dalemans, W. et al. (1991) "Altered chloride ion channel kinetics associated with the F508 cystic fibrosis mutation" Nature 354:526-528.
Dean, M. et al. (1990) "Multiple Mutations in Highly Conserved Residues Are Found in Mildly Affected Cystic Fibrosis" Cell 61:863-870.
Denning, G.M. et al. (1992) "Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive" Nature 358:761-764.
Deverson, E.V. (1990) "MHC class II regions encoding proteins related to the multidrug resistance family of transmembrane transporters" Nature 348:738-740.
Endicott, J.A. and V. Ling (1989) "The Biochemistry of P-Glycoprotein-Mediated Multidrug Resistance" Annu. Rev. Biochem. 58:137-171.
Fleisch, H. et al. (1991) "Biophosphates: Pharmacology and Use in the Treatment of Tumour-Induced Hypercalcaemic and Metastatic Bone Disease" Drugs 42(6):919-944.
Frizzell, R.A. et al. (1986) "Altered Regulation of Airway Epithelial Cell Chloride Channels in Cystic Fibrosis" Science 233:558-560.
Goldfischer, S. et al. (1973) "Peroxisomal and Mitochondrial Defects in the Cerebro-Hepato-Renal Syndrome" Science 182:62-64.
Goldstein, L.J. et al. (1989) "Expression of a Multidrug Resistance Gene in Human Cancers" J. Natl. Cancer Inst. 81:116-124.
Gottesman and Pastan (1988) "The Multidrug Transporter, a Double-edged Sword" J. Biol. Chem. 263:12163-12166.
Greene, L.E. and E. Eisenberg (1980) "Dissociation of the Actin-Subfragment 1 Complex by Adenyl-5'-yl Imidodiphosphate, ADP, and PP.sub.i " J. Biol. Chem. 255(2):543-548.
Gregory, R.J. et al. (1990) "Expression and characterization of the cystic fibrosis transmembrane conductance regulator" Nature 347:382-386.
Gros, P. et al. (1986) "Isolation and expression of a complementary DNA that confers multidrug resistance" Nature 323:728-731.
Gros, P. et al. (1986) "Mammalian Multidrug Resistance Gene: Complete cDNA Sequence Indicates Strong Homology to Bacterial Transport Proteins" Cell 47:371-380.
Gunderson, K.L. et al. (1994) "Effects of Pyrophosphate and Nucleotide Analogs Suggest a Role for ATP Hydrolysis in Cystic Fibrosis Transmembrane Regulator Channel Grating" J. Biol. Chem. 269(30):19349-19353.
Hamada, H. and T. Tsuruo (1988) "Purification of the 170- to 180-Kilodalton Membrane Glycoprotein Associated with Multidrug Resistance" J. Biol. Chem. 263:1454-1458.
Hartman, J. et al. (1992) "Recombinant Synthesis, Purification, and Nucleotide Binding Characteristics of the First Nucleotide Binding Domain of the Cystic Fibrosis Gene Product" J. Biol. Chem. 267:6455-6458.
Hwang, T.-C. et al. (1989) "CI.sup.- Channels in CF: Lack of Activation by Protein Kinase C and cAMP-Dependent Protein Kinase" Science 244:1351-1353.
Hwang, T.-C. et al. (1994) "Regulation of the gating of cystic fibrosis transmembrane conductance regulator C1 channels by phosphorylation and ATP hydrolysis" PNAS USA 91:4698-4702.
Hyde, S.C. et al. (1990) "Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport" Nature 346:362-365.
Imanaka, T. et al. (1987) "Translocation of Acyl-CoA Oxidase into Peroxisomes Requires ATP Hydrolysis but Not a Membrane Potential" J. Cell Biol. 105(6 Part 2):2915-2922.
Issartel, J.-P. et al. (1987) "Is Pyrophosphate an Analog of Adenosine Disphosphate for Beef Heart Mitochondrial F.sub.1 -ATPase" J. Biol. Chem. 262:13538-13544.
Kamijo, K. et al. (1990) "The 70-kDa Peroxisomal Membrane Protein Is a Member of the Mdr (P-glycoprotein)-related ATP-binding Protein Superfamily" J. Biol. Chem. 265(8):4534-4540.
Kerem, B.-S. et al. (1989) "Identification of the Cystic Fibrosis Gene: Genetic Analysis" Science 245:1073-1080.
Kerem, B.-S. et al. (1990) "Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene" PNAS USA 87:8447-8451.
Knowles, M.R. et al. (1991) "Activation by Extracellular Nucleotides of Chloride Secretion in the Airway Epithelia of Patients with Cystic Fibrosis" N. Eng. J. Med. 325(8):533-538.
Knowles, M.R. et al. (1990) "A Pilot Study of Aerosolized Amiloride for the Treatment of Lung Disease in Cystic Fibrosis" N. Eng. J. Med. 322(17):1189-1194.
Ko, Y.H. et al. (1994) "The Cystic Fibrosis Transmembrane Conductance Regulator" J. Biol. Chem. 269:14584-14588.
Kuchler, K. et al. (1989) "Saccharomyces cerevisiae STE6 gene product: a novel pathway for protein export in eukaryotic cells" EMBO J. 8(13):3973-3984.
Li, M. et al. (1988) "Cyclic AMP-dependent protein kinase opens chloride channels in normal but not cystic fibrosis airway epithelium" Nature 331:358-360.
Marshall, S.E. et al. (1990) "Selection and Evaluation of Recipients for Heart-Lung and Lung Transplantation" Chest 98: 1488-1494.
McElvaney, N.G. et al. (1991) "Aerosol 1-antitrysin treatment for cystic fibrosis" The Lancet 337:392-394.
Michel, L. et al. (1989) "Synthesis and Properties of Azidonitrophenyl Pyrophosphate, a Photoaffinity Probe of Nucleotide Binding Sites of Mitochondrial F.sub.1 -ATPase" Biochem. 28:10022-10028.
Monaco, J.J. et al. (1990) "Transport Protein Genes in Murine MHC: Possible Implications for Antigen Processing" Science 250:1723-1726.
Nagel, G. et al. (1992) "The protein kinase A-regulated cardiac CI.sup.- channel resembles the cystic fibrosis transmembrane conductance regulator" Nature 360:81-84.
Peinnequin, A. et al. (1992) "Does Pyrophosphate Bind to the Catalytic Sites of Mitochondrial F.sub.1 -ATPase?" Biochem. 31(7):2088-2092.
Quinton, P.M. (1990) "Cystic fibrosis: a disease in electrolyte transport" FASEB J. 4:2709-2717.
Reiner, M. et al. (1975) "Le traitment de la maladie de Paget par les diphosphonates (Treatment of Paget's

Affiliated with

Also associated with

Rating

Pharmaceutical compositions and uses of inorganic pyrophosphates does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions and uses of inorganic pyrophosphates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions and uses of inorganic pyrophosphates will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-703338